Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: A case-control study and literature review-Reference-Cited by-同舟云学术

Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: A case-control study and literature review

Published:2013-11-27 Issue:12 Volume:19 Page:1311-1317
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Duarte-Rojo Andres¹²,Budhraja Vikram²,Veldt Bart J.³,Goldstein David D.⁴,Watt Kymberly D.¹,Heimbach Julie K.⁵,McHutchison John G.⁴,Tillman Hans L.⁴,Poterucha John J.¹,Charlton Michael R.¹

Affiliation:

1. Divisions of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN

2. University of Arkansas for Medical Sciences; Little Rock AR

3. Department of Gastroenterology and Hepatology; Erasmus MC University Medical Center; Rotterdam the Netherlands

4. Duke Clinical Research Institute; Duke University Medical Center; Durham NC

5. Transplantation Surgery; Mayo Clinic; Rochester MN

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.23733/fullpdf

Reference23 articles.

1. Viral hepatitis in liver transplantation;Crespo;Gastroenterology,2012

2. Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation;Satapathy;Hepatol Res,2011

3. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation;Cimsit;Transplant Proc,2011

4. Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria;Narang;Liver Transpl,2010

5. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Current Limitations to Exercise Interventions After Liver Transplantation;Transplantation;2022-10-04

2. Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes;Scientific Reports;2017-06-30

3. Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival;Clinical Gastroenterology and Hepatology;2015-11

4. Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation;Clinical Gastroenterology and Hepatology;2015-11

5. Hepatitis C virus and liver transplantation: where do we stand?;Transplant International;2015-08-11